Tagged: vallovax

Batu Biologics Completes Equity Crowdfunding Round With $1.3 Million in Funding

Batu Biologics, an immuno-oncology company focused on the development and commercialization of novel therapies, announced on Monday the closing of its Regulation 506(c) equity crowdfunding offering on EquityNet after successfully securing $1.3 Million in funding. The funding round was launched in May 2017 and was… Read More

Send this to a friend